Spruce Biosciences Aktie
WKN DE: A2QD65 / ISIN: US85209E1091
|
05.02.2024 10:36:07
|
Biotech High-Flyers That Just Hit 52-Week Highs
(RTTNews) - In the biotech investment landscape, staying ahead of the curve is key to unlocking potential gains. The following biotech stocks, featured on our site, hit 52-week highs recently. Please note that the list is not exhaustive, and it represents merely a fraction of the high-performing stocks we have profiled.
*Last Closing Price refers to the stock's closing price on Feb.2, 2024.
Ticker | Published Date | Published Price | Maximum Price Since Publication | *Last Closing Price | Maximum Gain % |
|---|---|---|---|---|---|
May 26, 2023 | $9.54 | $18.10 | $17.75 | 89% | |
Oct.16, 2023 | $6.71 | $19.50 | $18.55 | 1.9 | |
Jan.22, 2024 | $15.52 | $39.62 | $39.15 | 155% | |
Mar.3, 2023 | $7.97 | $28.44 | $27.69 | 256% | |
Jan.2, 2024 | $12.53 | $16.88 | $15.22 | 35% | |
Aug.1, 2023 | $12.35 | $29.42 | $28.70 | 138% | |
Jul.10, 2023 | $31.30 | $50.20 | $47.24 | 60% | |
Nov.29, 2023 | $16.56 | $29.68 | $28.54 | 79% | |
Dec.19, 2023 | $11.22 | $14.76 | $14.59 | 31% | |
June 5, 2023 | $24.71 | $45 | $44.33 | 82% | |
Oct.31, 2023 | $8.75 | $14.49 | $14.26 | 65% | |
Dec.15, 2023 | $121.17 | $143.76 | $139.77 | 18% | |
Jan.25, 2024 | $2.57 | $3.90 | $3.52 | 51% | |
Nov.21, 2023 | $8.95 | $16.10 | $15.70 | 79% | |
Sep.15, 2023 | $4.99 | $14.07 | $14.00 | 182% | |
Sep.11, 2023 | $3.55 | $4.84 | $4.60 | 36% | |
Nov.28, 2023 | $23 | $47.11 | $46.15 | 105% | |
June 6, 2023 | $7.04 | $11.80 | $11.07 | 67% |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ascendis Pharma (spons. ADRs)mehr Nachrichten
|
06.08.25 |
Ausblick: Ascendis Pharma (spons ADRs) vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
|
30.04.25 |
Ausblick: Ascendis Pharma (spons ADRs) legt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu ProLung Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Alvotech Registered Shs | 7,02 | -1,13% |
|
| Ascendis Pharma (spons. ADRs) | 170,00 | -0,58% |
|
| Cullinan Management Inc Registered Shs | 7,73 | -4,80% |
|
| Edgewise Therapeutics Inc Registered Shs | 15,10 | 1,41% |
|
| IDEAYA Biosciences Inc Registered Shs | 23,80 | -1,65% |
|
| Ironwood Pharmaceuticals Inc (A) | 1,38 | 5,34% |
|
| KalVista Pharmaceuticals Inc | 9,35 | -0,53% |
|
| Morphosys AG (spons. ADRs) | 16,70 | 3,73% |
|
| Relmada Therapeutics Inc Registered Shs | 1,87 | 9,36% |
|
| RxSight Inc Registered Shs | 8,43 | -1,17% |
|
| Tarsus Pharmaceuticals Inc Registered Shs | 68,32 | -0,55% |
|
| Vera Therapeutics Inc Registered Shs -A- | 28,20 | -5,81% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.